2.60Open2.60Pre Close0 Volume65 Open Interest150.00Strike Price0.00Turnover81.89%IV8.95%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry2.60Extrinsic Value100Contract SizeAmericanOptions Type0.2867Delta0.0222Gamma53.87Leverage Ratio-0.4137Theta0.0067Rho15.45Eff Leverage0.0638Vega
ESCO Technologies Stock Discussion
In reaction to earnings/guidance:
• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics (AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7...
No comment yet